Confidence in Generic Drug Substitution

被引:11
作者
Lionberger, R. [1 ]
Jiang, W. [1 ]
Huang, S-M [2 ]
Geba, G. [1 ]
机构
[1] US FDA, Off Gener Drugs, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
[2] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
D O I
10.1038/clpt.2013.104
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Patients should have confidence that the generic drugs they are prescribed in the United States can be effectively substituted for the brand product or another generic product. Through new bioequivalence study designs for narrow therapeutic index (NTI) drugs and postapproval studies of generic substitution, the US Food and Drug Administration's (FDA's) ongoing generic drug regulatory science activities are designed to ensure successful generic substitution for all drug products.
引用
收藏
页码:438 / 440
页数:4
相关论文
共 9 条
[1]  
Anderson S, 1996, INT J CLIN PHARM TH, V34, P369
[2]  
Benet L.Z., 2004, APR 2004 FDA ADV COM
[3]  
Davit B., 2004, APR 2004 FDA ADV COM
[4]   Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration [J].
Davit, Barbara M. ;
Nwakama, Patrick E. ;
Buehler, Gary J. ;
Conner, Dale P. ;
Haidar, Sam H. ;
Patel, Devvrat T. ;
Yang, Yongsheng ;
Yu, Lawrence X. ;
Woodcock, Janet .
ANNALS OF PHARMACOTHERAPY, 2009, 43 (10) :1583-1597
[5]  
IMS Institute for Healthcare Informatics, 2012, GEN DRUG SAV US
[6]   Interchangeability of generic anti-epileptic drugs: a quantitative analysis of topiramate and gabapentin [J].
Maliepaard, Marc ;
Banishki, Nikola ;
Gispen-de Wied, Christine C. ;
Teerenstra, Steven ;
Elferink, Andre J. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (10) :1007-1016
[7]   State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid [J].
Shrank, William H. ;
Choudhry, Niteesh K. ;
Agnew-Blais, Jessica ;
Federman, Alex D. ;
Liberman, Joshua N. ;
Liu, Jun ;
Kesselheim, Aaron S. ;
Brookhart, M. Alan ;
Fischer, Michael A. .
HEALTH AFFAIRS, 2010, 29 (07) :1383-1390
[8]  
[US Food and Drug Administration Center for Drug Evaluation and Research (CDER)], 2012, GUID WARF S IN PRESS
[9]   Interchangeability of Gabapentin Generic Formulations in the Netherlands: A Comparative Bioavailability Study [J].
Yu, Y. ;
Teerenstra, S. ;
Vanmolkot, F. ;
Neef, C. ;
Burger, D. ;
Maliepaard, M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (04) :519-524